Qiagen NV | QIA - Operating Expenses

Stock Price
35.31
Daily Change
0.41 1.17%
Monthly
-13.24%
Yearly
-2.46%
Q2 Forecast
34.40

Qiagen NV reported $418.54M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Akebia Therapeutics USD 63.08M 8.26M Dec/2025
Alaunos Therapeutics USD 1.19M 148K Sep/2025
argenx SE USD 914.57M 137.58M Dec/2025
Avita Medical AUD 28.02M 1.55M Dec/2025
Dianthus Therapeutics USD 69.82M 29.14M Dec/2025
Ionis Pharmaceuticals USD 418M 101.1M Dec/2025
IQVIA Holdings USD 1.69B 4.47B Dec/2025
Moderna USD 1.54B 259M Dec/2025
Organon & Co USD 906M 362M Sep/2025
Qiagen NV USD 418.54M 23.25M Dec/2025
Revvity USD 626.22M 25.62M Dec/2025
Tectonic Therapeutic USD 21.52M 374K Dec/2025
Viatris USD 3.86B 335.7M Dec/2025
Xeris Pharmaceuticals USD 69.03M 1.38M Dec/2025